12:00 AM
 | 
May 10, 1999
 |  BC Week In Review  |  Company News  |  Deals

Cor, CuraGen deal

The companies signed a pharmacogenomics and product discovery collaboration under which CRGN will use its SeqCalling, GeneCalling and PathCalling SNP identification and differential gene expression technologies to identify drug targets. CORR...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >